Par'Immune

Par'Immune is a company engaged in immunoparasitogy research focusing on parasite molecules for immunotherapeutics. It develops a platform for autoimmune and inflammatory diseases, including bowel disease, Crohn’s disease, ulcerative colitis, and psoriasis.